Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Must Reads by Date

Must reads for theWeek ending October 25, 2015

Dyanavel XR Approved to Treat ADHD , Extended-release oral liquid for children 6 and older

First Large Trial of Aripiprazole and Risperidone, Metabolic outcomes, symptom alleviation evaluated

Drug Use Severity and Treatment Type Examined , When to offer collaborative vs specialized treatment

Cognition-Clinical Course Link in Schizophrenia, Is “pseudospecificity” an issue over time?

Decision Aid Helps with Treatment Selection, But…, …it has less of an impact on adherence and outcomes

More must reads

Must reads for theWeek ending October 18, 2015

Schizophrenia-Dementia Link Studied in Large Cohort, Risk in those over 50 but under 65 assessed

Predicting Conversion to Psychosis , Consider using these four variables

Cognitive Behavioral Prevention for MDD, Assessing its value when added to usual care

Role of Chronic Conditions in Dementia, Study looks at ‘multimorbidity’ effect on elderly

Connecting the Symptoms of MDD, Abnormal activation patterns seen in these areas

More must reads

Must reads for theWeek ending October 11, 2015

FDA Approves Atypical Antipsychotic Aristada , Extended-release injectable for schizophrenia

Generic Paliperidone Extended-Release , Indicated for schizophrenia in adults, adolescents

Role of Nutrition and Nutraceuticals in Psychiatry, New statement notes importance of integrative model

Predicting Psychosis Risk, These symptoms may have clinical utility

Aripiprazole Helps When Other Therapy Fails, But… , …tolerability can be an issue

More must reads

Must reads for theWeek ending October 4, 2015

Young Children with ADHD Symptoms , What clinicians should also look for…and why

Monitoring Increases Adherence in BD Patients, but…, …automated adherence monitoring does even better

Amyloidosis and Autosomal Dominant Alzheimer’s , A predictor of early cognitive decline?

CBT for Seasonal Affective Disorder , How does it compare to light therapy?

Frequency Discrimination and Emotion Recognition , BD patients with a history of psychosis are impacted

More must reads

Must reads for theWeek ending September 27, 2015

FDA Approves Atypical Antipsychotic Vraylar , Indications in schizophrenia, bipolar disorder

Adjunctive Therapy in Bipolar Disorder, Some benefit seen when armodafinil is added

Marijuana Use and Schizophrenia , Study looks at genetic link among early teen users

Many Elderly With MDD Do Not Respond to Meds, But… , …some do, and severity level is not the only factor

Using E-Cigarettes to Vaporize Cannabis , Survey shows prevalence among high school students

More must reads

Pages